Online First: Multi-Modal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification Across Disease States https://t.co/b1pFKU7THa

We're wrapping up #AACR25 on a strong note! Swing by the Exhibit Hall from now until 12pm CT to learn from our MSK experts and their work in clinical research and #cancer prevention. @AACR

Very glad to be presenting today at #AACR our work from the @PapaemmanuilLab on integrating multimodal data in Myeloid Neoplasms. Looking forward to an exciting poster session!

.@MFBerger1, @DSolit, @MLadanyi, and the MSK-Impact team accept the @AACR Team Science Award for developing and implementing a groundbreaking next-generation sequencing platform which has enabled the comprehensive molecular characterization of over 125,000 tumors. #AACR25

At #AACR25, stop by @kevinmboehm's poster to learn about his work training an artificial intelligence model to predict genetic changes in tumors by analyzing slide images. @MSKCancerCenter @AACR Learn more: https://t.co/hncGeKGdA9

Congratulations to @MSKCancerCenter MSK-IMPACT team and @OncoKB for receiving the #AACR25 TEAM Science Award! The impact of this team, assay & data to our understanding of cancer biology is unprecedented.

Thank you @PapaemmanuilLab! Great to be working with you and everyone in the lab.

A very warm thank you to everyone who has been part of this journey - really motivated for the chapters ahead!

Excited to present today with @DylanDomenico our workflow on interpretable classification of genomic variants in whole genome sequencing from archived tissue. If you're in Hawaii, come check out our work at the @icml_compbio Paper Online: https://t.co/XZ6vdacLwx #ICML2023

Another scientific journey, published. After years of receiving each others emails & being confused for one another at MDS meetings @eirinipapapetr1 &I decided to join forces to study SF3B1 mutated MDS.